BioCentury | Dec 8, 2014
Company News

Affymax management update

...Hired: Jonathan Couchman as president, CEO and a director, formerly CEO, CFO and chairman of Myrexis Inc. WIR...
BioCentury | Oct 27, 2014
Company News

Incyte management update

...Autoimmune, Hematology Hired: David Gryska as EVP and CFO, effective Oct. 31, formerly COO of Myrexis Inc....
BioCentury | Apr 1, 2013
Finance

1Q Stock Wrap-Up: Out fast at opening bell

...which is developing self-delivering RNAi. The steepest drop in the sub-$200 million segment came from Myrexis Inc....
...Mass. Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Japan Tissue Engineering Co. Ltd. (JASDAQ:7774), Aichi, Japan Myrexis Inc....
BioCentury | Feb 4, 2013
Company News

Myrexis cancer news

...also said that NASDAQ initiated proceedings to delist the company due to its belief that Myrexis...
...all the company's independent directors. The company could not be reached for details. Last September, Myrexis...
...a nine-month operating loss of $3.8 million. Myrexis Inc. (NASDAQ:MYRX), Salt Lake City, Utah Business: Cancer Myrexis...
BioCentury | Nov 12, 2012
Company News

BioFire management update

...City, Utah Business: Diagnostic, Supply/Service Hired: Robert Lollini as CFO, formerly CEO and CFO of Myrexis Inc. WIR...
BioCentury | Sep 10, 2012
Company News

EpiCept, Myrexis deal

...Myrexis terminated a 2003 deal and returned rights to cancer compound Azixa verubulin to EpiCept. Myrexis...
...said the compound is available for partnering. The companies did not disclose details. In March, Myrexis...
...its preclinical and clinical programs (see BioCentury, March 12). EpiCept Corp. (OTCQX:EPCT; SSE:EPCT), Tarrytown, N.Y. Myrexis Inc....
BioCentury | Aug 20, 2012
Company News

Myrexis autoimmune, cancer news

...said CEO Richard Brewer died from multiple myeloma. He was 61. Brewer joined cancer company Myrexis...
...Cancer Research and George Mark Children's House. Myrexis COO David Gryska will become acting CEO. Myrexis Inc....
BioCentury | Aug 16, 2012
Company News

Veteran biotech exec Brewer passes away

...said CEO Richard Brewer died from multiple myeloma. He was 61. Brewer joined cancer company Myrexis...
...board member at the Kellogg Graduate School of Management Center for Biotechnology at Northwestern University. Myrexis...
BioCentury | May 21, 2012
Company News

Myrexis management update

Myrexis Inc. (NASDAQ:MYRX), Salt Lake City, Utah Business: Cancer, Infectious Hired: Richard Brewer as president, CEO and a director, formerly CEO of Scios Inc. , which Johnson & Johnson acquired; he replaces Robert Lollini who stepped...
BioCentury | Mar 12, 2012
Company News

Myrexis cancer news

...BioCentury, Dec. 5, 2011 & Feb. 20, 2012). For its 2Q12 ending Dec. 31, 2011, Myrexis...
...multiforme (GBM). Myrexis has exclusive rights to Azixa from EpiCept Corp. (OTCQX:EPCT; SSE:EPCT, Tarrytown, N.Y.). Myrexis Inc....
Items per page:
1 - 10 of 84
BioCentury | Dec 8, 2014
Company News

Affymax management update

...Hired: Jonathan Couchman as president, CEO and a director, formerly CEO, CFO and chairman of Myrexis Inc. WIR...
BioCentury | Oct 27, 2014
Company News

Incyte management update

...Autoimmune, Hematology Hired: David Gryska as EVP and CFO, effective Oct. 31, formerly COO of Myrexis Inc....
BioCentury | Apr 1, 2013
Finance

1Q Stock Wrap-Up: Out fast at opening bell

...which is developing self-delivering RNAi. The steepest drop in the sub-$200 million segment came from Myrexis Inc....
...Mass. Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Japan Tissue Engineering Co. Ltd. (JASDAQ:7774), Aichi, Japan Myrexis Inc....
BioCentury | Feb 4, 2013
Company News

Myrexis cancer news

...also said that NASDAQ initiated proceedings to delist the company due to its belief that Myrexis...
...all the company's independent directors. The company could not be reached for details. Last September, Myrexis...
...a nine-month operating loss of $3.8 million. Myrexis Inc. (NASDAQ:MYRX), Salt Lake City, Utah Business: Cancer Myrexis...
BioCentury | Nov 12, 2012
Company News

BioFire management update

...City, Utah Business: Diagnostic, Supply/Service Hired: Robert Lollini as CFO, formerly CEO and CFO of Myrexis Inc. WIR...
BioCentury | Sep 10, 2012
Company News

EpiCept, Myrexis deal

...Myrexis terminated a 2003 deal and returned rights to cancer compound Azixa verubulin to EpiCept. Myrexis...
...said the compound is available for partnering. The companies did not disclose details. In March, Myrexis...
...its preclinical and clinical programs (see BioCentury, March 12). EpiCept Corp. (OTCQX:EPCT; SSE:EPCT), Tarrytown, N.Y. Myrexis Inc....
BioCentury | Aug 20, 2012
Company News

Myrexis autoimmune, cancer news

...said CEO Richard Brewer died from multiple myeloma. He was 61. Brewer joined cancer company Myrexis...
...Cancer Research and George Mark Children's House. Myrexis COO David Gryska will become acting CEO. Myrexis Inc....
BioCentury | Aug 16, 2012
Company News

Veteran biotech exec Brewer passes away

...said CEO Richard Brewer died from multiple myeloma. He was 61. Brewer joined cancer company Myrexis...
...board member at the Kellogg Graduate School of Management Center for Biotechnology at Northwestern University. Myrexis...
BioCentury | May 21, 2012
Company News

Myrexis management update

Myrexis Inc. (NASDAQ:MYRX), Salt Lake City, Utah Business: Cancer, Infectious Hired: Richard Brewer as president, CEO and a director, formerly CEO of Scios Inc. , which Johnson & Johnson acquired; he replaces Robert Lollini who stepped...
BioCentury | Mar 12, 2012
Company News

Myrexis cancer news

...BioCentury, Dec. 5, 2011 & Feb. 20, 2012). For its 2Q12 ending Dec. 31, 2011, Myrexis...
...multiforme (GBM). Myrexis has exclusive rights to Azixa from EpiCept Corp. (OTCQX:EPCT; SSE:EPCT, Tarrytown, N.Y.). Myrexis Inc....
Items per page:
1 - 10 of 84